| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/28/2010 | EP2178861A2 Heterocyclic amide compounds as protein kinase inhibitors |
| 04/28/2010 | EP2178858A1 Novel heterocyclic compounds as mglu5 antagonists |
| 04/28/2010 | EP2178856A1 Bispidon ligands and the metal complexes thereof |
| 04/28/2010 | EP2178373A1 Heterocycles as potassium channel modulators |
| 04/28/2010 | EP1805177B1 Pyrrolo[3,2-c]pyridine derivatives and process for the preparation thereof |
| 04/28/2010 | EP1581532B1 Pyrazolo¬3,4-b pyridine compounds, and their use as phosphodiesterase inhibitors |
| 04/28/2010 | EP1461339B1 Spiroazacyclic compounds as monoamine receptor modulators |
| 04/28/2010 | EP1420785B1 Substituted indeno [1,2-c]isoquinoline derivatives and methods of use thereof |
| 04/28/2010 | CN1751041B 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 04/28/2010 | CN1556705B 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives |
| 04/28/2010 | CN1553906B VARIOLIN derivatives and their use as antitumor agents |
| 04/28/2010 | CN1434043B Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 04/27/2010 | US7705153 chemokine coupled receptor 3 (CCR3); treating asthma; 1-(heteroarylcarbonyl)-4-piperidino-piperidine compounds |
| 04/27/2010 | US7705151 for treating inflammatory and allergic diseases; 2-methylnicotinic acid derivative is treated with a strong base such as lithium diisopropylamide (LDA) in a suitable solvent such as THF to form the dianion, followed by addition of a nitrile, to provide [1,6]-naphthyridin-5-ol, chlorinating with POCl3 |
| 04/27/2010 | US7705147 e.g.2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-(pyrimidine or pyridazine or piperazine)-pyrrole-5-carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive |
| 04/27/2010 | US7705017 Compounds for treatment of neurodegenerative diseases |
| 04/27/2010 | US7705015 Substituted pyrroline kinase inhibitors |
| 04/27/2010 | US7705013 Use of canthin-6-one, plant extracts containing same and derivatives thereof in the treatment of trypanosomiases |
| 04/27/2010 | US7705006 Anti-cancer cyclopenta[g]quinazoline compounds |
| 04/27/2010 | US7704996 Compounds and compositions useful as cathepsin S inhibitors |
| 04/27/2010 | US7704994 1-{6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3- pyridinyl}-2-pyrrolidinone and salts; histamine H3 antagonists; Alzheimer's disease; schizophrena; antiepileptic agents; analgesics; neuropathic pain; Parkinson's disease; attention deficit disorder |
| 04/27/2010 | US7704989 Derivatives of imidazo[1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics |
| 04/27/2010 | US7704987 Metal complex based on 1,10-phenanthroline binds to histidine of the N-terminal loop of the peptide in such a way that the N-terminal loop (amino acid residues 1-15) is blocked or destabilised to inhibit the binding copper, zinc and iron compounds -ones of magnesium /calcium; Alzheimer,s disease |
| 04/27/2010 | CA2551038C Triazole derivatives as vasopressin antagonists |
| 04/27/2010 | CA2449180C Viral polymerase inhibitors |
| 04/27/2010 | CA2437524C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 04/27/2010 | CA2422378C Pyrazole compounds useful as protein kinase inhibitors |
| 04/27/2010 | CA2387719C Azaindolizinone derivatives and cognitive enhancers comprising the same as effective components |
| 04/22/2010 | WO2010045303A2 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
| 04/22/2010 | WO2010045190A1 Fused heteroaryl diamide compounds useful as mmp-13 inhibitors |
| 04/22/2010 | WO2010045188A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
| 04/22/2010 | WO2010043893A1 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| 04/22/2010 | WO2010043539A1 Novel oxadiazolyl-diazabicyclononane derivatives and their medical use |
| 04/22/2010 | WO2010005528A3 Pyrrolopyridine carboxylic acid derivatives |
| 04/22/2010 | WO2009034546A3 Trans-decahydroisoquinoline derivatives |
| 04/22/2010 | US20100099877 New 2,9-dichloroquinacridone in platelet form |
| 04/22/2010 | US20100099700 Hydrogenated pyrido (4,3-b) indoles for treating amyotrophic lateral sclerosis (als) |
| 04/22/2010 | US20100099691 Pyrimidinyl pyridone inhibitors of jnk |
| 04/22/2010 | US20100099667 Bridged heterocyclic compounds and methods of use |
| 04/22/2010 | US20100099664 Substituted pyrrolidine amides, the production thereof, and the use thereof as medications |
| 04/22/2010 | US20100099663 4-trifluoromethoxyphenoxybenzol-4'-sulfonic acids, method for the production and use thereof in medicaments |
| 04/22/2010 | US20100099561 Heterobicyclic alkylthio-bridged isoxazolines |
| 04/22/2010 | US20100098634 Imaging Agents Useful for Identifying AD Pathology |
| 04/22/2010 | CA2739490A1 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
| 04/22/2010 | CA2739488A1 Fused heteroaryl diamide compounds useful as mmp-13 inhibitors |
| 04/22/2010 | CA2738929A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
| 04/22/2010 | CA2736335A1 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| 04/21/2010 | EP2177520A1 1,5-Di(aryl or heteroaryl)-3-halo-2(1H)-pyridones as intermediates for the preparation of AMPA receptor inhibitors |
| 04/21/2010 | EP2177518A1 Organic compounds |
| 04/21/2010 | EP2176263A2 Fused quinoline derivatives useful as gaba modulators |
| 04/21/2010 | EP2176262A1 Tricyclic compounds as antibacterials |
| 04/21/2010 | EP2176261A1 Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof |
| 04/21/2010 | EP2176260A1 Pyrazolo[1,5-a]pyridines and their use in cancer therapy |
| 04/21/2010 | EP2176259A1 Fused imidazoles for cancer treatment |
| 04/21/2010 | EP2176258A1 Piperidine derivatives useful as orexin receptor antagonists |
| 04/21/2010 | EP2176256A2 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 04/21/2010 | EP1963324B1 Heterocyclic compounds, their preparation and their use as antibacterials |
| 04/21/2010 | EP1888584B1 1, 6 -dihydro- 1,3, 5, 6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same as inhibitors of ikk enzyme activity |
| 04/21/2010 | EP1620082B1 Medical use of inhibitors of glutaminyl and glutamate cyclases for treating alzheimer's disease and down syndrome |
| 04/21/2010 | EP1268477B1 Substituted beta-carbolines with ikb-kinase inhibiting activity |
| 04/21/2010 | EP1258252B1 Integrin expression inhibitors |
| 04/21/2010 | EP1250328B2 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/21/2010 | CN1795195B Pyridopyrazines and the use thereof as kinase inhibitors |
| 04/21/2010 | CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/21/2010 | CN101696208A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
| 04/20/2010 | US7700777 Crystalline forms of a biphenyl compound |
| 04/20/2010 | US7700772 Amino heterocyclic modulators of chemokine receptor activity |
| 04/20/2010 | US7700630 3-Quinolin-2-ylmethylene-3,4,5,6-terahydro[2,3']bipyridinyl; for therapy and prophylaxis of psychotic diseases, neurodegenerative diseases involving a dysfunction of the cholinergic system |
| 04/20/2010 | US7700618 2-{[1-(cyclopropylmethyl)-2-(2,2-dimethylpropyl)-1H-benzimidazol-5-yl]sulfonyl}-N,N,2-trimethylpropanamide; condition mediated by CB2 receptors; less toxicity, good absorption, distribution, solubility, metabolic stability, less protein binding affinity other than CB2 receptor, less drug-drug interaction |
| 04/20/2010 | US7700617 Salt of naphthyridine carboxylic acid derivative |
| 04/20/2010 | US7700616 Compounds and amyloid probes thereof for therapeutic and imaging uses |
| 04/20/2010 | US7700609 antiproliferative agents; antiinflammatory agents; neurodegenerative agents; autoimmune disease; viricides |
| 04/20/2010 | US7700608 Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 04/20/2010 | US7700604 (5S)-5-methyl-5-({[6-[2-(trifluoromethyl)pyrimidin-5-yl]-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)imidazolidine-2,4-dione; asthma, rhinitis, chronic obstructive pulmonary diseases (COPD), arthritis (such as rheumatoid arthritis and osteoarthritis), atherosclerosis, cancer |
| 04/20/2010 | US7700589 Such as 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylic acid-{(R)-1-(3,4-diethyl-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amide; calcitonin gene related peptide (CGRP); for treatment of migraines; radioimmunoassay |
| 04/20/2010 | US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 04/20/2010 | CA2561950C 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 04/20/2010 | CA2417475C Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacterien |
| 04/20/2010 | CA2404311C Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems |
| 04/15/2010 | WO2010042799A2 Novel chimeric ligand-gated ion channels and methods of use thereof |
| 04/15/2010 | WO2010042646A1 Aza- and diaza-phthalazine compounds as p38 map kinase modulators and methods of use thereof |
| 04/15/2010 | WO2010041711A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 04/15/2010 | WO2010041218A2 Oxazolidinyl antibiotics |
| 04/15/2010 | WO2010041194A1 Tricyclic oxazolidinone antibiotic compounds |
| 04/15/2010 | WO2010041112A1 Novel combinations of antibacterial nitrogenous heterocyclic compounds with other antibacterial compounds, and use thereof as drugs |
| 04/15/2010 | WO2010041054A1 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer |
| 04/15/2010 | WO2010040663A1 Pyrrolidine n-benzyl derivatives |
| 04/15/2010 | US20100094013 Process for production of prasugrel hydrochloride having high purity |
| 04/15/2010 | US20100094012 Heterodiamondoids |
| 04/15/2010 | US20100093788 Heterocyclic benzimidazoles as trpm8 modulators |
| 04/15/2010 | US20100093784 Novel heterocyclic nitrogenous compounds, their preparation and their use as antibacterial medicaments |
| 04/15/2010 | US20100093782 Pyrazolonaphthyridine derivatives |
| 04/15/2010 | US20100093781 Imidazo [1, 2-a] pyrrolo [3, 2-c] pyridine compounds useful as pestivirus inhibitors |
| 04/15/2010 | US20100093777 Spiro-ring compound |
| 04/15/2010 | US20100093775 Compounds and methods for the treatment or prevention of flavivirus infections |
| 04/15/2010 | US20100093771 Compound having bicyclic pyrimidine structure and pharmaceutical composition comprising the same |
| 04/15/2010 | US20100093767 Mitotic Kinase Inhibitors |
| 04/15/2010 | US20100093761 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/15/2010 | US20100093759 Bicyclic anilide heterocyclic cgrp receptor antagonists |
| 04/15/2010 | US20100093752 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors |